Anti-human pulmonary carcinoma monoclonal antibody
US4892935A · kind A · utility
34Cited by
3References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 6, 1987 |
| Grant date | Jan 9, 1990 |
| Priority date | — |
| Expiry date | Jul 6, 2007 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S530/861
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
Monoclonal antibodies being capable of reacting with human squamous cell lung carcinoma, lung adenocarcinoma and large cell lung carcinoma, and non-reactive with human small cell lung carcinoma and normal human lung cells, and recognizing glycoproteins as antigens. Hybridomas having the characteristics of cell line SLC-454 secrete such antibodies. Method of diagnosing human lung cancer and method of therapeutic treatment are described.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.